Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder

Journal of Neurology

Volumn 260, Issue 12, 2013, Pages 3150-3157

  Long, Youming ^a   He, Yihua ^a   Zheng, Yangbo ^a   Chen, Mengyu ^a   Zhang, Bin ^a   Gao, Cong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Anticardiolipin antibody; Multiple sclerosis; Neuromyelitis optica; Outcome

Indexed keywords

AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; DEXAMETHASONE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PREDNISONE; WARFARIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLINDNESS; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; PRIORITY JOURNAL; QUADRIPLEGIA; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; SPINAL CORD LESION;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIGENS; CARDIOLIPINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84890658744     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7128-3     Document Type: Article

References (30)

1. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P (2003) Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 9(5):521-525
2. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485-1489
3. Pittock SJ, Lennon VA, de Seze J et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78-83
4. Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106-2112
5. Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR (2000) Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 79(1):57-68
6. Czlonkowska A, Sliwinska A (2007) Multiple sclerosis and antiphospholipid syndrome - difficulties in differential diagnostics. Pol Arch Med Wewn 117(Suppl):28-32
7. Akhter E, Shums Z, Norman GL, Binder W, Fang H, Petri M (2013) Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus. J Rheumatol 40(3):282-286
8. El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behcet's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies. Rheumatol Int 21(5):176-181
9. IJdo JW, Conti-Kelly AM, Greco P et al (1999) Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS. Lupus 8(2):109-115
10. Bidot CJ, Horstman LL, Jy W et al (2007) Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol 7:36
11. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K (1993) Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 88(3):184-189
12. Sugiyama Y, Yamamoto T (1996) Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis. Tohoku J Exp Med 178(3):203-215
13. Karussis D, Leker RR, Ashkenazi A, Abramsky O (1998) A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity. Ann Neurol 44(4):629-634
14. Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B et al (2012) Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus 21(4):412-420
15. Cordoliani MA, Michon-Pasturel U, Rerat K et al (1998) Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients. Rev Med Interne 19(9):635-639
16. Carrillo-Mora P, Gonzalez-Villalva A (2010) Clinical characteristics and presence of antiphospholipid antibodies (anticardiolipin-beta2GP-1) cerebrospinal fluid and serum of in a series of patients with multiple sclerosis in Mexico. Neurologia 25(2):71-77
17. D'Olhaberriague L, Levine SR, Salowich-Palm L et al (1998) Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases. Neurology 51(5):1376-1380
18. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805-815
19. Sato DK, Nakashima I, Takahashi T et al (2013) Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 80(24):2210-2216
20. Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292-302
21. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444-1452
22. Huang Q, Lan X, Tong T et al (1996) Dot-immunogold filtration assay as a screening test for syphilis. J Clin Microbiol 34(8):2011-2013
23. Long Y, Qiu W, Lu Z et al (2012) Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica. Neuroimmunomodulation 19(2):96-102
24. Mealy MA, Wingerchuk DM, Greenberg BM, Levy M (2012) Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol 69(9):1176-1180
25. Heinzlef O, Weill B, Johanet C et al (2002) Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry 72(5):647-649
26. Ito H, Nagasato K, Nakamura T, Tsujihata M, Nagataki S (1992) Transverse myelopathy in a patient with systemic lupus erythematosus associated with positive anticardiolipin antibody - a case report. Rinsho Shinkeigaku 32(6):639-641
27. Spadaro M, Amendolea MA, Mazzucconi MG et al (1999) Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler 5(2):121-125
28. Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D (1990) Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 17(1):34-37
29. D'Cruz DP, Mellor-Pita S, Joven B et al (2004) Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 31(2):280-285
30. Wingerchuk DM (2013) Neuromyelitis optica: potential roles for intravenous immunoglobulin. J Clin Immunol 33(Suppl 1):S33-S37